3. Al-Sawaf O, Cramer P, Goede V, Hallek M, Pflug N. Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review. Ther Adv Hematol, 2017:8(6);197–205
4. MIMS Indonesia. Bendamustine. 2021.
https://www.mims.com/indonesia/drug/info/bendamustine?mtype=generic
6. National Center for Biotechnology Information (2021). PubChem Compound Summary for CID 77082, Bendamustine hydrochloride. Retrieved March 19, 2021 from https://pubchem.ncbi.nlm.nih.gov/compound/Bendamustine-hydrochloride.
9. Patekar M B. Bendamustine: an old drug in the new era for patients with non-hodgkin lymphomas and chronic lymphocytic leukemia. Acta Clin Croat 2018; 57:542-553
10. Cheson B D, et al. Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel-an update. Leukemia & Lymphoma, 2016:57:766-82